Genmab — Marts 2016
-
Det er jo helt væk at kursen ikke snart stiger
-
Så må vi håbe på CHMP i næste uge. Hvis alt går godt, bliver dara indstillet til godkendelse fredag næste uge.
-
Agendaen bliver vel snart offentliggjort. Så vi endelig kan bryde 860
-
Bristol-Myers Squibb Co. said Wednesday that it would acquire privately-held Padlock Therapeutics Inc. in a deal potentially valued at up to $600 million, the latest attempt by a large pharmaceutical company to grab a chunk of the growing autoimmune disease market.
-
God Påske!
Nyheden om Dara i solide tumors kan udvikle sig til noget meget stort! Det er ugens bedste nyhed for den langsigtede.
Jeg kan se der et par steder har været spekuleret i indikationen. Jeg vover pelsen og gætter på på det er prostata cancer. Bedre bud?
-
Lungekræft og blærekræft. Fordi Jan fremhæver i Medwatch at
Roche midlet har vist gode resultater der
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
